Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia (CLL): Preliminary data.

被引：0
|
作者：
Cazin, B
Binet, JL
Divine, M
Lepretre, S
Lederlin, P
Travade, P
Lemaire, G
Guibon, O
机构：
[1] CHU Lille, F-59037 Lille, France
[2] CHU, Paris, France
[3] CHU, Creteil, France
[4] CHU, Rouen, France
[5] CHU, Nancy, France
[6] CHU, Clermont Ferrand, France
[7] Schering SA, Dardilly, France
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2218
引用
收藏
页码：515A / 515A
页数：1
相关论文
共 50 条
  • [31] Lumiliximab with fludarabine, cyclophosphamide, and rituximab (FCR) for patients with relapsed chronic lymphocytic leukemia (CLL).
    O'Brien, S.
    Byrd, J. C.
    Kipps, T. J.
    Forero-Torres, A.
    Flinn, I. W.
    Wynne, D. I.
    Molina, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 360S - 360S
  • [32] Therapy with fludarabine, cyclophosphamide and rituximab (FCR) for relapsed or untreated progressive chronic lymphocytic leukemia (CLL). A single center experience.
    Pavlovsky, Carolina
    Pavlovsky, Ntiago
    Pardo, Maria L.
    Sapia, Sandra
    Monreal, Maricla
    Corrado, Claudia
    Pavlovsky, Miguel A.
    Fernandez, Isolda
    Juni, Mariana
    BLOOD, 2006, 108 (11) : 329B - 329B
  • [33] Comparison of fludarabine (F) plus cyclophosphamide (C) versus FC plus rituximab (R) in previously untreated Rai stage III/IV chronic lymphocytic leukemia (CLL).
    Parikh, S. A.
    Wierda, W. G.
    Badoux, X.
    O'Brien, S. M.
    Ferrajoli, A.
    Faderl, S.
    Burger, J. A.
    Lerner, S.
    Kantarjian, H.
    Keating, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] COMPARISON OF CLADRIBINE PLUS CYCLOPHSOPHAMIDE OR FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN DIFFERENT AGE GROUPS IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (PALG-CLL3 STUDY)
    Robak, T.
    Blonski, J. Z.
    Gora-Tybor, J.
    Jamroziak, K.
    Konopka, L.
    Ceglarek, B.
    Calbecka, M.
    Kostyra, A.
    Stella-Holowiecka, B.
    Kloczko, J.
    Warzocha, K.
    Seferynska, I.
    Dmoszynska, A.
    Kowal, M.
    Lewandowski, K.
    Dwilewicz-Trojaczek, J.
    Wiater, E.
    Kuliczkowski, K.
    Potoczek, S.
    Hellmann, A.
    Mital, A.
    Skotnicki, A.
    Nowak, W.
    Sulek, K.
    Zdunczyk, A.
    Dybowicz, J.
    Zawilska, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 36 - 36
  • [35] Combination chemo-antibody therapy with fludarabine (F), cyclophosphamide (C) and rituximab (R) achieves a high CR rate in previously untreated chronic lymphocytic leukemia (CLL).
    Keating, MJ
    O'Brien, S
    Lerner, S
    Giles, F
    Andreeff, M
    Cortes, J
    Albitar, M
    Kantarjian, H
    BLOOD, 2000, 96 (11) : 514A - 514A
  • [36] Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase IISWOG TRIAL 9706
    Hussein, MA
    Gundacker, H
    Head, DR
    Elias, L
    Foon, KA
    Boldt, DH
    Dobin, SM
    Dakhil, SR
    Budd, GT
    Appelbaum, FR
    LEUKEMIA, 2005, 19 (11) : 1880 - 1886
  • [37] COMPARISON OF FLUDARABINE (FDB), CAP AND CHOP IN ADVANCED PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - PRELIMINARY-RESULTS OF A RANDOMIZED CLINICAL-TRIAL
    BINET, JL
    CHASTANG, C
    CHEVRET, S
    DIGHIERO, G
    MALOUM, K
    TRAVADE, P
    BLOOD, 1993, 82 (10) : A140 - A140
  • [38] Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
    Nicole Lamanna
    Mark A. Weiss
    Current Hematologic Malignancy Reports, 2009, 4 (4) : 185 - 186
  • [39] Fludarabine and cyclophosphamide achieves high complete response rate in patients with previously untreated chronic lymphocytic leukemia: ECOG 1997.
    Flinn, IW
    Jemiai, Y
    Bennett, JM
    Falkson, CI
    Flynn, P
    Pundaleeka, S
    Stadtmauer, E
    Schnell, F
    Grever, M
    Tallman, MS
    Rowe, JM
    BLOOD, 2001, 98 (11) : 633A - 633A
  • [40] Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study
    Leblond, Veronique
    Cantin, Guy
    Cortelezzi, Agostino
    Knauf, Wolfgang
    Tiab, Mourad
    Turgut, Mehmet
    Zaritskey, Andrey
    Merot, Jean-Louis
    Trunzer, Kerstin
    Robson, Susan
    Gresko, Ekaterina
    Stilgenbauer, Stephan
    Foa, Robin
    Bosch, Francesc
    BLOOD, 2017, 130
12345